Trade Summary

5 days ago, Freeman Chris, serving as Chief Commercial Officer at Guardant Health, Inc. (GH), sold 24,406 shares at $118.67 per share, for a total transaction value of $2,896,360.08. Following this transaction, Freeman Chris now holds 60,034 shares of GH.

This sale represents a 28.90% decrease in Freeman Chris's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 5:38 PM ET, 4 days after the trade was made.

Guardant Health, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.